Skye Bioscience Responds to OTC Markets Promotional Policy
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, focusing on metabolic conditions and glaucoma, has received a request by OTC Markets Group Inc....